Financial Management Professionals’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$915K Sell
7,239
-122
-2% -$16.1K 0.09% 79
2026
Q1
$1.03M Buy
7,361
+257
+4% +$36K 0.12% 64
2025
Q4
$872K Sell
7,104
-8
-0.1% -$972 0.09% 74
2025
Q3
$789K Buy
7,112
+49
+0.7% +$5.57K 0.08% 76
2025
Q2
$783K Sell
7,063
-421
-6% -$44.8K 0.09% 73
2025
Q1
$839K Buy
7,484
+208
+3% +$21.5K 0.11% 65
2024
Q4
$672K Buy
7,276
+887
+14% +$79.9K 0.09% 79
2024
Q3
$536K Buy
6,389
+92
+1% +$7.02K 0.07% 85
2024
Q2
$432K Buy
6,297
+419
+7% +$28K 0.06% 90
2024
Q1
$431K Buy
5,878
+361
+7% +$27.8K 0.06% 93
2023
Q4
$447K Buy
5,517
+572
+12% +$44.5K 0.07% 77
2023
Q3
$371K Buy
4,945
+626
+14% +$48.1K 0.07% 82
2023
Q2
$333K Buy
4,319
+198
+5% +$15.8K 0.06% 87
2023
Q1
$342K Sell
4,121
-1,030
-20% -$85.3K 0.07% 88
2022
Q4
$442K Buy
5,151
+711
+16% +$56.3K 0.09% 68
2022
Q3
$274K Buy
4,440
+323
+8% +$20.4K 0.06% 78
2022
Q2
$254K Buy
4,117
+585
+17% +$36.2K 0.06% 88
2022
Q1
$210K Buy
3,532
+1,219
+53% +$77.9K 0.05% 99
2021
Q4
$168K Buy
2,313
+104
+5% +$7.16K 0.04% 107
2021
Q3
$154K Sell
2,209
-11
-0.5% -$773 0.04% 103
2021
Q2
$153K Buy
2,220
+575
+35% +$38.4K 0.04% 106
2021
Q1
$106K Buy
1,645
+121
+8% +$7.8K 0.03% 126
2020
Q4
$89K Buy
1,524
+44
+3% +$2.65K 0.03% 138
2020
Q3
$94K Buy
1,480
+11
+0.7% +$763 0.03% 113
2020
Q2
$113K Buy
1,469
+1,119
+320% +$85.8K 0.04% 87
2020
Q1
$26K Sell
350
-55
-14% -$3.8K 0.01% 123
2019
Q4
$26K Buy
405
+55
+16% +$3.58K 0.01% 134
2019
Q3
$22K Hold
350
0.01% 136
2019
Q2
$24K Hold
350
0.01% 133
2019
Q1
$23K Hold
350
0.01% 121
2018
Q4
$22K Hold
350
0.01% 116
2018
Q3
$27K Hold
350
0.01% 110
2018
Q2
$25K Hold
350
0.01% 117
2018
Q1
$26K Hold
350
0.01% 115
2017
Q4
$25K Hold
350
0.01% 99
2017
Q3
$28K Sell
350
-39
-10% -$2.98K 0.01% 96
2017
Q2
$27K Hold
389
0.01% 103
2017
Q1
$26K Hold
389
0.01% 104
2016
Q4
$27K Sell
389
-101
-21% -$7.51K 0.01% 109
2016
Q3
$38K Sell
490
-29
-6% -$2.36K 0.02% 111
2016
Q2
$42K Buy
519
+29
+6% +$2.57K 0.02% 96
2016
Q1
$45K Buy
490
+201
+70% +$18.1K 0.02% 74
2015
Q4
$39K Hold
289
0.02% 84
2015
Q3
$28K Hold
289
0.02% 106
2015
Q2
$33K Sell
289
-39
-12% -$4.26K 0.02% 105
2015
Q1
$32K Hold
328
0.02% 105
2014
Q4
$31K Buy
328
+78
+31% +$8.07K 0.02% 122
2014
Q3
$26K Hold
250
0.02% 120
2014
Q2
$20K Hold
250
0.01% 131
2014
Q1
$18K Hold
250
0.01% 134
2013
Q4
$19K Buy
+250
New +$17.4K 0.01% 135

Other funds holding GILD

Financial Management Professionals's GILD Position: Q2 2026 in Review

Financial Management Professionals reduced its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, selling an estimated $16.1K and leaving 7,239 shares worth $915K. The position accounts for 0.09% of the portfolio, ranked #79.

Financial Management Professionals first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.03M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Financial Management Professionals held 7,239 shares of Gilead Sciences worth $915K as of Q2 2026.
  • Financial Management Professionals sold 122 Gilead Sciences shares in Q2 2026, an estimated $16.1K.
  • Gilead Sciences made up 0.09% of Financial Management Professionals's portfolio in Q2 2026, its #79 holding.
  • Financial Management Professionals first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
  • Financial Management Professionals's Gilead Sciences position peaked at $1.03M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.